Could a drug prescribed for over six decades hold the key to not just managing diabetes, but also slowing brain aging and extending life? Scientists have recently unveiled a groundbreaking discovery: Metformin, a common type 2 diabetes medication, primarily works directly in the brain, challenging the long-held belief that its effects were limited to the liver and gut. Researchers at the Baylor College of Medicine pinpointed a specific brain pathway in the ventromedial hypothalamus, demonstrating that Metformin targets a protein called Rap1 to combat diabetes. This profound insight opens the door to developing new, more targeted diabetes treatments that could boost the drug’s efficacy and potentially reduce side effects. Astonishingly, Metformin is also recognized for its gerotherapeutic properties, shown to slow brain aging and improve lifespan, with one study indicating a 30 percent lower risk of dying before age 90 in certain women taking the drug. While human studies are essential to confirm these findings, this revelation fundamentally changes our understanding of Metformin’s vast potential, extending its utility far beyond blood sugar management. Don’t miss out on future health breakthroughs; make sure to subscribe to our channel for the latest scientific insights!
Follow us on social media:
– X: @BollyMirch
– Instagram: @bollymirch
📱 Tags & Keywords:
#metformin #diabetes #brain #aging #longevity #drugmechanism #ventromedialhypothalamus #rap1 #healthresearch #bloodglucose
About the Author
